161 related articles for article (PubMed ID: 18178537)
21. Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.
Gazzerro E; Deregowski V; Stadmeyer L; Gale NW; Economides AN; Canalis E
Bone; 2006 Dec; 39(6):1252-60. PubMed ID: 16934545
[TBL] [Abstract][Full Text] [Related]
22. Knock-in of nuclear localised beta-galactosidase reveals that the tyrosine phosphatase Ptprv is specifically expressed in cells of the bone collar.
Dacquin R; Mee PJ; Kawaguchi J; Olmsted-Davis EA; Gallagher JA; Nichols J; Lee K; Karsenty G; Smith A
Dev Dyn; 2004 Apr; 229(4):826-34. PubMed ID: 15042706
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the bone phenotype in ClC-7-deficient mice.
Neutzsky-Wulff AV; Karsdal MA; Henriksen K
Calcif Tissue Int; 2008 Dec; 83(6):425-37. PubMed ID: 18958510
[TBL] [Abstract][Full Text] [Related]
24. Recql4 haploinsufficiency in mice leads to defects in osteoblast progenitors: Implications for low bone mass phenotype.
Yang J; Murthy S; Winata T; Werner S; Abe M; Prahalad AK; Hock JM
Biochem Biophys Res Commun; 2006 May; 344(1):346-52. PubMed ID: 16600186
[TBL] [Abstract][Full Text] [Related]
25. A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation.
Kodama N; Nagata M; Tabata Y; Ozeki M; Ninomiya T; Takagi R
Bone; 2009 Apr; 44(4):699-707. PubMed ID: 19166987
[TBL] [Abstract][Full Text] [Related]
26. Insulin receptor isoforms are differently expressed during human osteoblastogenesis.
Avnet S; Perut F; Salerno M; Sciacca L; Baldini N
Differentiation; 2012 Jun; 83(5):242-8. PubMed ID: 22466604
[TBL] [Abstract][Full Text] [Related]
27. A role for receptor tyrosine phosphatase zeta in glioma cell migration.
Müller S; Kunkel P; Lamszus K; Ulbricht U; Lorente GA; Nelson AM; von Schack D; Chin DJ; Lohr SC; Westphal M; Melcher T
Oncogene; 2003 Oct; 22(43):6661-8. PubMed ID: 14555979
[TBL] [Abstract][Full Text] [Related]
28. Osteoblast-specific Angiopoietin 1 overexpression increases bone mass.
Suzuki T; Miyamoto T; Fujita N; Ninomiya K; Iwasaki R; Toyama Y; Suda T
Biochem Biophys Res Commun; 2007 Nov; 362(4):1019-25. PubMed ID: 17825261
[TBL] [Abstract][Full Text] [Related]
29. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice.
Sobue T; Naganawa T; Xiao L; Okada Y; Tanaka Y; Ito M; Okimoto N; Nakamura T; Coffin JD; Hurley MM
J Cell Biochem; 2005 May; 95(1):83-94. PubMed ID: 15723277
[TBL] [Abstract][Full Text] [Related]
30. Potential involvement of the interaction between insulin-like growth factor binding protein (IGFBP)-6 and LIM mineralization protein (LMP)-1 in regulating osteoblast differentiation.
Strohbach C; Kleinman S; Linkhart T; Amaar Y; Chen ST; Mohan S; Strong D
J Cell Biochem; 2008 Aug; 104(5):1890-905. PubMed ID: 18395833
[TBL] [Abstract][Full Text] [Related]
31. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
33. Receptor protein tyrosine phosphatases are expressed by cycling retinal progenitor cells and involved in neuronal development of mouse retina.
Horvat-Bröcker A; Reinhard J; Illes S; Paech T; Zoidl G; Harroch S; Distler C; Knyazev P; Ullrich A; Faissner A
Neuroscience; 2008 Mar; 152(3):618-45. PubMed ID: 18308476
[TBL] [Abstract][Full Text] [Related]
34. Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro.
Ideno H; Takanabe R; Shimada A; Imaizumi K; Araki R; Abe M; Nifuji A
Exp Cell Res; 2009 Feb; 315(3):474-84. PubMed ID: 19073177
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice.
Zhou H; Mak W; Kalak R; Street J; Fong-Yee C; Zheng Y; Dunstan CR; Seibel MJ
Development; 2009 Feb; 136(3):427-36. PubMed ID: 19141672
[TBL] [Abstract][Full Text] [Related]
36. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice.
Margolis DS; Szivek JA; Lai LW; Lien YH
Calcif Tissue Int; 2008 Jan; 82(1):66-76. PubMed ID: 18175028
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
39. Expression and localization of plasma transglutaminase factor XIIIA in bone.
Nakano Y; Al-Jallad HF; Mousa A; Kaartinen MT
J Histochem Cytochem; 2007 Jul; 55(7):675-85. PubMed ID: 17341477
[TBL] [Abstract][Full Text] [Related]
40. Gene array profile identifies collagen type XV as a novel human osteoblast-secreted matrix protein.
Lisignoli G; Codeluppi K; Todoerti K; Manferdini C; Piacentini A; Zini N; Grassi F; Cattini L; Piva R; Rizzoli V; Facchini A; Giuliani N; Neri A
J Cell Physiol; 2009 Aug; 220(2):401-9. PubMed ID: 19365806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
